Skip to content
10-Q

Quarterly Report

ZS Pharma, Inc.

0001193125-15-281000

← back to feed
Filed
Aug 6, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Aug 3, 2015 25.12M sh
Capex Q2 2015 · Jun 30, 2015 $1.76M
Capex Q2 2015 · Jun 30, 2014 $3.73M
Long Term Debt Q2 2015 · Jun 30, 2015 $8.71M
Long Term Debt Q2 2015 · Dec 31, 2014 $9.96M
Short Term Debt Q2 2015 · Jun 30, 2015 $1.39M
Short Term Investments Q2 2015 · Jun 30, 2015 $155.44M
Short Term Investments Q2 2015 · Dec 31, 2014 $54.88M
Cash And Equivalents Q2 2015 · Jun 30, 2015 $77.42M
Cash And Equivalents Q2 2015 · Dec 31, 2014 $47.4M
Cash And Equivalents Q2 2015 · Jun 30, 2014 $130M
Cash And Equivalents Q2 2015 · Dec 31, 2013 $9.17M
Stockholders Equity Q2 2015 · Jun 30, 2015 $228.34M
Stockholders Equity Q2 2015 · Dec 31, 2014 $96.77M
Current Liabilities Q2 2015 · Jun 30, 2015 $12.83M
Current Liabilities Q2 2015 · Dec 31, 2014 $9.14M
Total Liabilities Q2 2015 · Jun 30, 2015 $22.69M
Total Liabilities Q2 2015 · Dec 31, 2014 $19.39M
Current Assets Q2 2015 · Jun 30, 2015 $235.22M
Current Assets Q2 2015 · Dec 31, 2014 $103.26M
Total Assets Q2 2015 · Jun 30, 2015 $251.03M
Total Assets Q2 2015 · Dec 31, 2014 $116.16M
Sga Expense Q2 2015 · Jun 30, 2015 $15.16M
Sga Expense Q2 2015 · Jun 30, 2015 $21.57M
Sga Expense Q2 2015 · Jun 30, 2014 $2.88M
Sga Expense Q2 2015 · Jun 30, 2014 $5.3M
Rd Expense Q2 2015 · Jun 30, 2015 $17.29M
Rd Expense Q2 2015 · Jun 30, 2015 $32.61M
Rd Expense restated Q2 2015 · Jun 30, 2014 $11.65M
Rd Expense restated Q2 2015 · Jun 30, 2014 $18.5M
Net Income Q2 2015 · Jun 30, 2015 −$32.6M
Net Income Q2 2015 · Jun 30, 2015 −$54.55M
Net Income Q2 2015 · Jun 30, 2014 −$16.43M
Net Income Q2 2015 · Jun 30, 2014 −$27.18M
Operating Income Q2 2015 · Jun 30, 2015 −$32.45M
Operating Income Q2 2015 · Jun 30, 2015 −$54.17M
Operating Income Q2 2015 · Jun 30, 2014 −$14.53M
Operating Income Q2 2015 · Jun 30, 2014 −$23.81M